TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 10604083

Group type: EXPERIMENTAL
Intervention: Treatment responders (n=21)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Completely recovered responders (n=11)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Unimproved subjects (n=7)
Number of subjects: 28
Study: 7561414

Group type: EXPERIMENTAL
Intervention: External fixation
Number of subjects: 90

Group type: COMPARATOR
Intervention: Pins and plaster
Number of subjects: 90

Group type: COMPARATOR
Intervention: Both groups (external fixation and pins and plaster)
Number of subjects: 90
Study: 2025165

Group type: EXPERIMENTAL
Intervention: CCC technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Can opener technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Linear capsulotomy technique
Number of subjects: 40

Group type: COMPARATOR
Intervention: Capsulopuncture technique
Number of subjects: 40
Study: 6988785

Group type: EXPERIMENTAL
Intervention: Balanced protein‐calorie supplementation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High protein supplementation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 30286636

Group type: EXPERIMENTAL
Intervention: Excision and primary closure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Limberg flap technique
Number of subjects: 60
Study: 28017706

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 5-kHz current
Number of subjects: 38

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 38
Study: 25834203

Group type: EXPERIMENTAL
Intervention: Subcutaneous tocilizumab (TCZ‐SC) monotherapy, 162 mg every 2 weeks (q2w)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Subcutaneous tocilizumab (TCZ‐SC) monotherapy
Number of subjects: 319

Group type: COMPARATOR
Intervention: Intravenous tocilizumab (TCZ‐IV) monotherapy, 8 mg/kg every 4 weeks
Number of subjects: 319
Study: 23570275

Group type: EXPERIMENTAL
Intervention: Telemedical service center (TmSC) management of home monitoring (HM) data
Number of subjects: 55
Study: 21300808

Group type: EXPERIMENTAL
Intervention: Bear-hug test at varying arm positions (ideal position, 10° superior, 10° inferior to the shoulder line)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Belly-press test at varying arm positions (ideal position, maximum shoulder external rotation, and maximal shoulder internal rotation)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lift-off test at varying arm positions (ideal position, hand position 5 in. [12.7 cm] superior and 5 in. [12.7 cm] inferior to the midlumbar spine)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Comparison across the 3 tests (bear-hug, belly-press, lift-off)
Number of subjects: 20
Study: 19433686

Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐alpha‐2b
Number of subjects: 1256

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 1256
Study: 17539986

Group type: EXPERIMENTAL
Intervention: Pantoprazole 40 mg daily
Number of subjects: 582

Group type: EXPERIMENTAL
Intervention: Esomeprazole 40 mg daily
Number of subjects: 582
Study: 12774231

Group type: EXPERIMENTAL
Intervention: Four tasks resulting from a factorial combination of two types of judgment and two judgment-to-response mappings
Number of subjects: 0

Group type: COMPARATOR
Intervention: Two tasks occurring in each block of trials
Number of subjects: 0
Study: 11361054

Group type: EXPERIMENTAL
Intervention: Troglitazone 400 mg for 24 days with simvastatin 40 mg on Days 15-24
Number of subjects: 2

Group type: COMPARATOR
Intervention: Simvastatin 40 mg for 10 days
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Pioglitazone 45 mg for 24 days with simvastatin 80 mg on Days 15-24
Number of subjects: 2

Group type: COMPARATOR
Intervention: Simvastatin 80 mg for 10 days
Number of subjects: 2
Study: 9624541

Group type: EXPERIMENTAL
Intervention: Enoxacin (400 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (500 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Norfloxacin (400 mg)
Number of subjects: 12
Study: 8033544

Group type: EXPERIMENTAL
Intervention: 1% SLG solution
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 1% surfactant mixture solutions (M1, M2, M3)
Number of subjects: 15

Group type: COMPARATOR
Intervention: M1 (75/25 SLG/SLS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: M2 (50/50 SLG/SLS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: M3 (25/75 SLG/SLS)
Number of subjects: 15

Group type: COMPARATOR
Intervention: 1% SLS solution
Number of subjects: 15
Study: 2480029

Group type: EXPERIMENTAL
Intervention: HES 200/0.5 10% with exercise
Number of subjects: 75

Group type: COMPARATOR
Intervention: Ringer lactate with exercise
Number of subjects: 75

Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 75
Study: 241306

Group type: EXPERIMENTAL
Intervention: Chlordiazepoxide
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31580310

Group type: EXPERIMENTAL
Intervention: Experimental manoeuvre (passive contralateral knee mobilization into extension)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo manoeuvre
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control manoeuvre
Number of subjects: 38
Study: 27986412

Group type: EXPERIMENTAL
Intervention: Physical Activity (PA)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Health Education (HE)
Number of subjects: 26
Study: 26210908

Group type: EXPERIMENTAL
Intervention: Brief asthma education plus motivational interviewing counseling
Number of subjects: 165

Group type: COMPARATOR
Intervention: Asthma education alone (Control)
Number of subjects: 165
Study: 24236382

Group type: EXPERIMENTAL
Intervention: Manipulation of power perception in the out-group (the USA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Manipulation of perceived harmony of intergroup interests
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 21443416

Group type: EXPERIMENTAL
Intervention: Probiotic fermented milk (500 ml daily containing at least 5 × 10(7) CFU/ml of Lactobacillus paracasei ssp paracasei F19, Lactobacillus acidophilus La5, and Bifidobacterium lactis Bb12)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Acidified milk (equal volume to probiotic fermented milk)
Number of subjects: 64
Study: 18205759

Group type: EXPERIMENTAL
Intervention: Early rehabilitation program
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study: 16611288

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol 4000 (0.50 g/kg)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Lactulose (1.5 g/kg)
Number of subjects: 67
Study: 14666025

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid and Aprotinin
Number of subjects: 60
Study: 11062279

Group type: EXPERIMENTAL
Intervention: Emergency medical services (EMS) arrival
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Total delay time (symptom onset until CT scan completion)
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Time from symptom onset to ED arrival
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Time from ED arrival until CT scan completion
Number of subjects: 1207
Study: 9007165

Group type: EXPERIMENTAL
Intervention: Gallopamil
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 1508765

Group type: EXPERIMENTAL
Intervention: Mason suture technique
Number of subjects: 57

Group type: COMPARATOR
Intervention: Reinforced continuous six-strand suture technique
Number of subjects: 57
Study: 6356319

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g qid)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Cimetidine (300 mg qid)
Number of subjects: 29
Study: 31490310

Group type: EXPERIMENTAL
Intervention: Continuous sutures (CS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interrupted sutures (IS)
Number of subjects: 0
Study: 30478975

Group type: EXPERIMENTAL
Intervention: Augmented usual care and additional nurse support (Intervention)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Augmented usual care (Control)
Number of subjects: 95
Study: 26588357

Group type: EXPERIMENTAL
Intervention: Implant placement (IMP)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Fixed partial denture (FPD)
Number of subjects: 120
Study: 26118315

Group type: EXPERIMENTAL
Intervention: Dasatinib
Number of subjects: 519

Group type: COMPARATOR
Intervention: Imatinib
Number of subjects: 519
Study: 24934242

Group type: EXPERIMENTAL
Intervention: mini‐cardiopulmonary bypass (mCPB)
Number of subjects: 26

Group type: COMPARATOR
Intervention: conventional cardiopulmonary bypass (cCPB)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both mCPB and cCPB
Number of subjects: 26
Study: 22933495

Group type: EXPERIMENTAL
Intervention: Circumpatellar electrocautery (diathermy)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control (no circumpatellar electrocautery)
Number of subjects: 200
Study: 19152545

Group type: EXPERIMENTAL
Intervention: Objects associated with feelings of effort during goal pursuit
Number of subjects: 0

Group type: COMPARATOR
Intervention: Objects associated with feelings of ease
Number of subjects: 0
Study: 17064857

Group type: EXPERIMENTAL
Intervention: lofexidine + naloxone
Number of subjects: 137

Group type: COMPARATOR
Intervention: lofexidine + placebo
Number of subjects: 137

Group type: COMPARATOR
Intervention: methadone
Number of subjects: 137
Study: 15125846

Group type: EXPERIMENTAL
Intervention: Single caudal epidural injection of 20 ml containing bupivacaine and tramadol
Number of subjects: 82

Group type: COMPARATOR
Intervention: Single caudal epidural injection of 20 ml of normal saline
Number of subjects: 82
Study: 11555126

Group type: EXPERIMENTAL
Intervention: Citalopram (SSRI) for 6 months
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 16
Study: 9856165

Group type: EXPERIMENTAL
Intervention: Human albumin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Withholding albumin or administration of crystalloid fluids
Number of subjects: 0
Study: 8185469

Group type: EXPERIMENTAL
Intervention: Younger patients (45 years old or younger)
Number of subjects: 1353

Group type: EXPERIMENTAL
Intervention: Patients older than 45 years but 65 years old or younger
Number of subjects: 1353

Group type: EXPERIMENTAL
Intervention: Patients older than 65 years
Number of subjects: 1353

Group type: COMPARATOR
Intervention: Age considered in a Cox's multivariate model
Number of subjects: 1353
Study: 3237594

Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB) with 7% citric acid
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB) with water
Number of subjects: 8

Group type: COMPARATOR
Intervention: Citric acid alone
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: A1-containing phosphate binder (ACPB)
Number of subjects: 8
Study: 29432045

Group type: EXPERIMENTAL
Intervention: Conditional economic incentive of R300 cash (∼$23) for starting ART within 3 months
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group (no incentive)
Number of subjects: 86
Study: 27342383

Group type: EXPERIMENTAL
Intervention: 1g of TXA intraoperative, followed by another postoperative
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: 2g preoperative
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (no TXA)
Number of subjects: 240
Study: 24731899

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT) for headache pain management, 8-week duration
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy (MBCT)
Number of subjects: 21
Study: 23727917

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine 3 µg
Number of subjects: 54

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 54
Study: 21130942

Group type: EXPERIMENTAL
Intervention: CCMIC (microincisional cataract surgery)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional phacoemulsification
Number of subjects: 37
Study: 17179023

Group type: EXPERIMENTAL
Intervention: Nutrient-enriched formula (28% more protein than standard formula)
Number of subjects: 299

Group type: COMPARATOR
Intervention: Standard formula
Number of subjects: 299
Study: 15180118

Group type: EXPERIMENTAL
Intervention: P-NMES
Number of subjects: 15
Study: 11230831

Group type: EXPERIMENTAL
Intervention: Percutaneous myocardial laser revascularization (PMR)
Number of subjects: 40
Study: 9502454

Group type: EXPERIMENTAL
Intervention: piperacillin-tazobactam (TAZ; 4 g/0.5 g q.i.d.) + amikacin (7.5 mg/kg b.i.d.)
Number of subjects: 204

Group type: COMPARATOR
Intervention: ceftazidime (CAZ; 1 g q.i.d.) + amikacin (7.5 mg/kg b.i.d.)
Number of subjects: 204
Study: 8310997

Group type: EXPERIMENTAL
Intervention: Yogurt enriched with Bifidobacterium longum and 5 g lactulose/L (A)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Conventional yogurt (B)
Number of subjects: 12
Study: 3402355

Group type: EXPERIMENTAL
Intervention: urapidil 120 mg once daily
Number of subjects: 36

Group type: COMPARATOR
Intervention: urapidil 60 mg twice daily
Number of subjects: 36
Study: 28947166

Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening of elbow and wrist flexors/extensors
Number of subjects: 20

Group type: COMPARATOR
Intervention: Passive joint mobilization (control group)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Isokinetic strengthening
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Whole sample
Number of subjects: 20
Study: 25738793

Group type: EXPERIMENTAL
Intervention: RCL (rescuers changed by a team leader's decision)
Number of subjects: 96

Group type: COMPARATOR
Intervention: RC2 (conventional rescuer rotation method, rescuers changed in 2-min intervals)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: RCL
Number of subjects: 96

Group type: COMPARATOR
Intervention: RC2
Number of subjects: 96
Study: 25335248

Group type: EXPERIMENTAL
Intervention: Scraping therapy (44 cases)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Acupuncture therapy (41 cases)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Both scraping and acupuncture therapies
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Scraping therapy
Number of subjects: 85
Study: 23660718

Group type: EXPERIMENTAL
Intervention: Ultrasonic fundus‐first dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional laparoscopic cholecystectomy using electrocautery
Number of subjects: 0
Study: 20631341

Group type: EXPERIMENTAL
Intervention: 3B(90)E(500)P (30 kU bleomycin on days 1, 8, and 15; 100 mg/m(2) etoposide on days 1‐5; 20 mg/m(2) cisplatin on days 1‐5; n = 83)
Number of subjects: 166

Group type: COMPARATOR
Intervention: 4B(30)E(360)P (30 kU bleomycin on day 1; 120 mg/m(2) etoposide on days 1‐3; 100 mg/m(2) cisplatin on day 1; n = 83)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: 3B(90)E(500)P
Number of subjects: 166

Group type: COMPARATOR
Intervention: 4B(30)E(360)P
Number of subjects: 166
Study: 19378539

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine (S50-R50)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine (S75-R25)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine (S75-R25)
Number of subjects: 75
Study: 16804655

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (P/T) at 4 g/0.5 g
Number of subjects: 221

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (I/C) at 1 g/1 g
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Piperacillin/tazobactam (P/T)
Number of subjects: 221

Group type: COMPARATOR
Intervention: Imipenem/cilastatin (I/C)
Number of subjects: 221
Study: 15014276

Group type: EXPERIMENTAL
Intervention: Grafton DBM
Number of subjects: 120

Group type: COMPARATOR
Intervention: Iliac crest autograft
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both Grafton DBM and Iliac crest autograft
Number of subjects: 120
Study: 11544831

Group type: EXPERIMENTAL
Intervention: Endolymphic infusion of immunomodulator
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Regional infusion of considerable doses of cytostatic mixes
Number of subjects: 85
Study: 9750678

Group type: COMPARATOR
Intervention: Clonidine (C)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 12
Study: 8144799

Group type: EXPERIMENTAL
Intervention: Hirudin
Number of subjects: 246

Group type: COMPARATOR
Intervention: Heparin
Number of subjects: 246
Study: 3415886

Group type: EXPERIMENTAL
Intervention: 2% lignocaine with adrenaline 1 in 200,000 in the lateral position
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 0.5% plain bupivacaine in the sitting position
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Hypotension (defined as a 25% or greater reduction in arterial pressure)
Number of subjects: 64
Study: 31418585

Group type: EXPERIMENTAL
Intervention: Abaloparatide 80 µg daily
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Teriparatide 20 µg daily
Number of subjects: 2463

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2463
Study: 28493932

Group type: EXPERIMENTAL
Intervention: Ulinastatin (3×105 U to 80×105 U)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 26242335

Group type: EXPERIMENTAL
Intervention: Dynamic lumbar posterior instrumentation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Conservative treatment with an exercise program
Number of subjects: 53
Study: 23545150

Group type: EXPERIMENTAL
Intervention: Iloprost
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 21496991

Group type: EXPERIMENTAL
Intervention: Personalized motivational intervention (PMI)
Number of subjects: 218

Group type: COMPARATOR
Intervention: Health-information (HI) control
Number of subjects: 218
Study: 19559433

Group type: EXPERIMENTAL
Intervention: Hands-on skills training for therapeutic endoscopic procedures
Number of subjects: 28

Group type: COMPARATOR
Intervention: Knowledge-based teaching
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control group (no hands-on skills training)
Number of subjects: 28
Study: 16374763

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound after first-trimester uterine evacuation
Number of subjects: 809

Group type: COMPARATOR
Intervention: Control group (no ultrasound)
Number of subjects: 809
Study: 12757679

Group type: EXPERIMENTAL
Intervention: Low ligation (Inguinal approach/Ivanissevich's procedure) - Group I (n: 115)
Number of subjects: 213

Group type: COMPARATOR
Intervention: High ligation (Retroperitoneal approach/modified Palomo's procedure) - Group II (n: 98)
Number of subjects: 213
Study: 10967180

Group type: EXPERIMENTAL
Intervention: Stimulation of digital nerves at frequencies of 2 Hz, 3 Hz, 5 Hz, 7 Hz, and 9 Hz with 500 stimuli given at each frequency.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Reflex responses recorded from the triceps brachii muscle in 8 subjects.
Number of subjects: 20
Study: 9118190

Group type: EXPERIMENTAL
Intervention: Chlorhexidine/xylitol chewing gum
Number of subjects: 53

Group type: COMPARATOR
Intervention: Xylitol placebo chewing gum
Number of subjects: 53
Study: 8416238

Group type: EXPERIMENTAL
Intervention: High-current stimulation
Number of subjects: 11

Group type: COMPARATOR
Intervention: Low-current stimulation
Number of subjects: 11
Study: 2944534

Group type: EXPERIMENTAL
Intervention: Ethinyloestradiol 50 micrograms/cyproterone acetate 50 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ethinyloestradiol 50 micrograms/norgestrel 500 micrograms (Eugynon 50)
Number of subjects: 24
Study: 30770539

Group type: EXPERIMENTAL
Intervention: Slightly sweet lipid-based nutrient supplement (LNS)
Number of subjects: 985

Group type: COMPARATOR
Intervention: Control group (non-LNS) received iron and folic acid or multiple micronutrients
Number of subjects: 985

Group type: COMPARATOR
Intervention: Control group (non-LNS)
Number of subjects: 985
Study: 28180236

Group type: EXPERIMENTAL
Intervention: Community In‐reach Rehabilitation and Care Transition (CIRACT) service
Number of subjects: 250

Group type: COMPARATOR
Intervention: Traditional hospital‐based rehabilitation (THB‐Rehab) service
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: CIRACT service
Number of subjects: 250

Group type: COMPARATOR
Intervention: THB‐Rehab service
Number of subjects: 250
Study: 26097440

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.4 g · kg(‐1) body weight)
Number of subjects: 13
Study: 24332698

Group type: EXPERIMENTAL
Intervention: Pharmacologic cardioversion (PCV)
Number of subjects: 2972

Group type: EXPERIMENTAL
Intervention: Electrical cardioversion (ECV)
Number of subjects: 2972
Study: 22588508

Group type: EXPERIMENTAL
Intervention: Video feedback intervention (n = 25)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Verbal feedback intervention (n = 26)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Standard care (n = 23)
Number of subjects: 74
Study: 19139776

Group type: EXPERIMENTAL
Intervention: Group I (n=27) received 15 ml (102.5mg) of 0.75% solution
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Group II (n=27) received 10 ml (75 mg) of 0.75% solution
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Group III (n=27) received 10 ml (50mg) 0.5% ropivacaine
Number of subjects: 81
Study: 18232268

Group type: EXPERIMENTAL
Intervention: Double-fortified salt (DFS)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: Iodised salt plus weekly 70 mg iron supplement (IS + iron)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Iodised salt (IS) plus weekly placebo (control group)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Iodised salt (IS) (control group)
Number of subjects: 286

Group type: EXPERIMENTAL
Intervention: All groups of women and children
Number of subjects: 286
Study: 15111940

Group type: EXPERIMENTAL
Intervention: Physical methods, especially with the use of biological feedback
Number of subjects: 173

Group type: COMPARATOR
Intervention: Pharmacological treatments
Number of subjects: 173

Group type: COMPARATOR
Intervention: Combination of pharmacological and physical treatments
Number of subjects: 173
Study: 11758290

Group type: EXPERIMENTAL
Intervention: Interrater agreement between two readers
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Interrater agreement between readers and authors
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Categories assigned by methodologists
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Categories assigned by authors
Number of subjects: 160